| Generic Name |
Brand Name |
Breast cancer type |
Breast cancer stage |
Where in the drug approval process is this treatment |
| Atezolizumab |
Tecentriq |
Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved |
| Capecitabine |
Xeloda; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Carboplatin |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Cisplatin |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Cyclophosphamide |
Procytox; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Docetaxel |
Taxotere; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Doxorubicin |
Adriamycin; Myocet; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Epirubicin |
Pharmorubicin; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Eribulin |
Halaven |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Fluorouracil |
Actikerall; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Gemcitabine |
Gemzar; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Methotrexate |
Metoject; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Mitoxantrone |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Olaparib |
Lynparza |
HR+, HER2-, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved |
| Olaparib |
Lynparza |
HR+, HER2-, Triple Negative |
Stage 0, I, II, III |
Listed on Provincial Drug Formulary |
| Paclitaxel |
Taxol; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Paclitaxel-nab |
Abraxane |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Pegylated Liposomal Doxorubicin |
Caelyx |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved |
| Pembrolizumab |
Keytruda |
Triple Negative |
Stage IV (metastatic) |
PCPA - Approved; Provincial Review Ongoing |
| Pembrolizumab |
Keytruda |
Triple Negative |
Stage 0, I, II, III |
Listed on Provincial Drug Formulary |
| Sacituzumab govitecan |
Trodelvy |
Triple Negative |
Stage IV (metastatic) |
PCPA - Approved; Provincial Review Ongoing |
| Temozolomide |
Temodal; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
| Vinorelbine |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |